Does adjuvant hepatic artery infusion chemotherapy improve patient outcomes for hepatocellular carcinoma following liver resection? A meta-analysis

BACKGROUND: Adjuvant hepatic artery infusion chemotherapy (HAIC) has been shown to be beneficial to the patient outcomes in hepatocellular carcinoma (HCC). METHODS: Randomized controlled trials (RCTs) and non-RCTs were identified from six databases up to January 26, 2023. Patient outcomes were asses...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Lingbo, Zheng, Yu, Lin, Jiangyin, Shi, Xingpeng, Wang, Aidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069128/
https://www.ncbi.nlm.nih.gov/pubmed/37013589
http://dx.doi.org/10.1186/s12957-023-03000-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069128/
https://www.ncbi.nlm.nih.gov/pubmed/37013589
http://dx.doi.org/10.1186/s12957-023-03000-1

Ejemplares similares